InterMune, KDL GmbH, Marnac deal

Marnac and KDL sold worldwide rights to patents covering pirfenidone to ITMN for $13.5 million up front and up to $53.5 million in milestones. The rights exclude Japan, South Korea and Taiwan and undi...